Atjaunināt sīkdatņu piekrišanu

Oxford Textbook of Neurologic and Neuropsychiatric Epidemiology [Hardback]

Edited by (Director, National Institute for Stroke and Applied Neuroscience (NISAN),, Auckland Universit), Edited by , Edited by (Professor of Public Health Medicine and Director, Cambridge University Department of Public Health, University of Cambridge, Cambridge, UK), Edited by
  • Formāts: Hardback, 512 pages, height x width x depth: 284x224x34 mm, weight: 1672 g
  • Sērija : Oxford Textbooks in Clinical Neurology
  • Izdošanas datums: 02-Nov-2020
  • Izdevniecība: Oxford University Press
  • ISBN-10: 019874949X
  • ISBN-13: 9780198749493
Citas grāmatas par šo tēmu:
  • Hardback
  • Cena: 178,26 €
  • Grāmatu piegādes laiks ir 3-4 nedēļas, ja grāmata ir uz vietas izdevniecības noliktavā. Ja izdevējam nepieciešams publicēt jaunu tirāžu, grāmatas piegāde var aizkavēties.
  • Daudzums:
  • Ielikt grozā
  • Piegādes laiks - 4-6 nedēļas
  • Pievienot vēlmju sarakstam
  • Formāts: Hardback, 512 pages, height x width x depth: 284x224x34 mm, weight: 1672 g
  • Sērija : Oxford Textbooks in Clinical Neurology
  • Izdošanas datums: 02-Nov-2020
  • Izdevniecība: Oxford University Press
  • ISBN-10: 019874949X
  • ISBN-13: 9780198749493
Citas grāmatas par šo tēmu:
Neurologic and neuropsychiatric disorders are of great importance to societies and they also raise special considerations in epidemiological research methodology. Not only do neurologic and neuropsychiatric disorders form a major group of disorders associated with ageing populations, but those disorders that occur in earlier life can be associated with severe individual, family, and societal distress and burden. The inter-relationship of syndromes and disorders is a topic of major interest and growing biological insights across psychiatry and neurology. This includes not only overlaps in neurodegenerative syndromes but also those related to other systems such as metabolic, inflammatory, immune and vascular disorders.

Part of the Oxford Textbooks in Clinical Neurology series, the Oxford Textbook of Neurologic and Neuropsychiatric Epidemiology is designed to focus on the overlaps and inter-relationships between neuro-epidemiological disorders, as well as on ways to harmonise large cohort studies to maximise opportunities for determining causes related to rarer disorders. Divided into three main parts, the book covers 1) the principles of neurologic and neuropsychiatric epidemiology; 2) specific neuropsychiatric disorders and their inter-relationships and 3) the implications of neuro-epidemiologic research for patient populations and current medical practice. This comprehensive work serves as an invaluable reference to current neuro-epidemiological methods for neurologists, psychiatrists, and senior trainees in those disciplines, as well as public health practitioners and students with an interest in neurology and neuropsychiatry.
Abbreviations xiii
Contributors xvii
SECTION 1 Concepts, designs, and methods
1 A historical perspective on neurological and neuropsychiatric definitions
3(6)
German E. Berrios
Ivana S. Markova
2 Neuroimaging and fluid biomarkers of Alzheimer's disease: implications for definition, diagnosis, and treatment
9(12)
Vijay R. Varma
Yi-Fang Chuang
Madhav Thambisetty
3 Life course, exposure, and ageing populations
21(8)
Yoav Ben-Shlomo
4 Examining trends in dementia incidence and prevalence using an age-period-cohort framework
29(8)
Kenneth M. Langa
Eileen M. Crimmins
Mark D. Hayward
5 Overview of common designs, measures of effect, and biases in neuroepidemiological studies
37(10)
Derrick A. Bennett
6 Conducting research in low- and middle-income settings
47(10)
Maelenn Guerchet
Rosie Mayston
A. Matthew Prina
7 Trial designs, including observational to interventional
57(8)
Edo Richard
8 Cardiometabolic morbidities and dementia
65(10)
Chengxuan Qiu
Davide Liborio Vetrano
Laura Fratiglioni
SECTION 2 Neurodegenerative disorders
9 Early onset Alzheimer's disease
75(8)
Ratnavalli Eliajosyula
10 Huntington's disease
83(10)
Juliana R. Dutra
Tanya P. Garcia
Karen Marder
11 Idiopathic Parkinson's disease and classification of parkinsonisms
93(22)
Valentina Gallo
Honglei Chen
Neil Pearce
12 Dementia and Parkinson's disease
115(4)
Rodolfo Savica
Pierpaolo Turcano
13 Amyotrophic lateral sclerosis (ALS) and fronto-temporal dementia (FTD)
119(14)
Giancarlo Logroscino
Adriano Chio
14 Rare neurodegenerative parkinsonism (PSR MSA, CBD)
133(8)
James B. Rowe
Ian T.S. Coyle-Gilchrist
15 Posterior cortical atrophy
141(12)
Keir X.X. Yong
S.J. Crutch
J.M. Schott
16 Epidemiology of essential tremor
153(12)
Elan D. Louis
SECTION 3 Dementia as final common outcome
17 Detecting dementia early in populations
165(6)
Amy R. Borenstein
18 The oldest-old and dementia at the end of life
171(12)
Maria M. Corrada
Claudia H. Kawas
SECTION 4 Vascular disorders
19 Global stroke burden and prevention strategies: findings from GBD 2015
183(10)
Rita Krishnamurthi
Valery L. Feigin
20 Stroke and TIA
193(10)
Bo Norrving
21 Small vessel disease
203(10)
Fergus N. Doubal
Anna Poggesi
Leonardo Pantoni
Joanna M. Wardlaw
22 Migraine: descriptive epidemiology and related neurobiology
213(14)
Julio R. Vieira
Richard B. Upton
SECTION 5 Neurology, neuropsychiatry, and phenomenology
23 The clinical spectrum of neurodegenerative disease: moving beyond mild cognitive impairment
227(12)
Stina Saunders
Graciela Muniz-Terrera
Tom C. Russ
Craig W. Ritchie
Karen Ritchie
24 The epidemiology of apathy in neurological disorders
239(8)
Sergio Starkstein
Bradleigh Hayhow
Pierre Wibawa
25 Behavioural and psychological symptoms of dementia
247(12)
Rianne van der Linde
Tom Dening
26 Delirium
259(8)
Daniel Davis
Sarah Richardson
Esteban Sepulveda
27 Methods and approaches to examining the interface of late-life depression and dementia
267(10)
Mirjam I. Geerlings
28 Epidemiology of schizophrenia and related disorders
277(18)
Assen Jablensky
Hannah E. Jongsma
James B. Kirkbride
Peter B. Jones
SECTION 6 Other key neurological conditions
29 Multiple sclerosis: descriptive epidemiology and related neurobiology
295(8)
Elisabeth Gulowsen Celius
30 Myasthenia gravis
303(10)
Anne Taraldsen Heldal
Nils Erik Gilhus
31 Epilepsy
313(18)
Ettore Beghi
Giorgia Giussani
Torbjorn Tomson
32 Neuropathies: descriptive epidemiology and related neurobiology
331(14)
Ettore Beghi
Giorgia Giussani
Marco Poloni
33 Sensory loss-vision
345(10)
Paul J. Foster
Anthony Khawaja
Usanne J. Balk
Zaynah Muthy
Axel Petzold
34 Sensory loss---hearing
355(12)
Adele M. Goman
Frank R. Lin
SECTION 7 Infections, exposures, injuries, and the brain
35 The neuroepidemiology of human prion disease
367(12)
Patrick J.M. Urwin
Anna M. Molesworth
36 Epidemiology of bacterial and parasitic infections of the central nervous system
379(8)
Charles R. Newton
37 Infection, other than bacterial, including HIV
387(10)
Ines Yoro-Zohoun
Jaime Luna
Salmane Amidou
Pierre-Marie Preux
38 Traumatic brain and spinal cord injury
397(10)
Alice Theadom
Kelly M. Jones
39 Electromagnetic fields
407(10)
Joachim Schuz
Maria Feychting
40 Metals and neurodegeneration
417(10)
Susan Peters
Anne E. Visser
Marc Weisskopf
Marianthi-Anna Kioumourtzoglou
Roel Vermeulen
SECTION 8 Global health and public health
41 Estimating the global burden of stroke: methods and challenges
427(14)
Thomas Truelsen
Catherine Johnson
Mohsen Naghavi
Theo Vos
Valery L. Feigin
Gregory Roth
42 What is the role of trials and other `well-designed' studies in the understanding of neurological and neuropsychiatric conditions
441(4)
Carol Brayne
43 Research and methodologic opportunities and challenges conducting research among US military personnel
445(8)
Ann I. Scher
David W. Niebuhr
Darrell Singer
44 Global evidence generation
453(12)
Adesola Ogunniyi
45 The role of prevention in common neurological disorders
465(14)
Giancarlo Logroscino
Carol Brayne
Rosanna Tortelli
Index 479
Carol Brayne CBE is Professor of Public Health Medicine at the University of Cambridge and Director of the Cambridge Institute of Public Health. Graduating from the Royal Free Hospital School of Medicine at the University of London in 1981, she went on to train in general medicine from 1982-1983. Since then, her work has been focused around longitudinal studies of the neurological health of older people from a public health perspective. Since joining Cambridge, she has been appointed chair of the Faculty of Public Health, Academic & Research Comittee, CLAHRC theme lead, Special Adivsor to the Royal College of Physicians, fellow of the Academy of Sciences, and co-chair of the Alzherimer's Society Research Strategy Council. Listed among the highest cited scholars in the world in 2018, Professor Brayne was awarded a CBE for services to public health medicine in the Queen's 2017 Honours.



Professor Valery Feigin is the director of Auckland University of Technology's National Institute for Stroke and Applied Neuroscience (NISAN), associate director of the Centre for Neurocomputation and Brain Study at KEDRI, and affiliate professor of the Department of Global Health at the Institute for Health Metrics and Evaluation at the University of Washington. A current board member of the World Stroke Organisation, Professor Feigin's work focuses predominantly on stroke, TBI, treatment, and epidemiology. He has authored or co-authored over 600 academic publications, and been cited over 31,000 times, and currently serves as Editor-in-Chief of the journal Neuroepidemiology. Feigin has received numerous awards over his career, including the Bruce Shoenburh International Award and Lecture in Neuropepidemiology, the Fogarty International Centre Research Grant Award, and the World Stroke Organization President's award for his services to stroke research.



Dr. Launer is a senior investigator at the National Institute on Aging in Bethesda, Maryland. In 1987, she received her PhD in Epidemiology and Nutrition from Cornell University, after which she undertook a three year post-doctoral fellowship at NICHD. She has held positions at the National Insitute of Health and the Environment and Erasmus University, where she led and was involved with numerous large-scale epidemiological studies into dementia and migraine. Since 1999, she has led the Neuroepidemiology section of the NIA Laboratory of Epidemiology, Demography, and Biometry, where she has researched the genetic, inflammatory, vascular, metabolic, and hormonal factors of sub-clinical and clinical outcomes in brain disease.



Giancarlo Logroscino, MD PhD is Professor of Neurology and director of the Neurodegenerative Diseases Unit at The University of Bari, and Chair of the Department of Clinical Research in Neurology at Pia Fondazione Panico in Tricase (LE). His primary research interests are natural history of neurodegenerative diseases and environmental risk factors for neurodegenerative diseases related to aging. He has been President of the Neuroepidemiological Italian Association (NEP), a member of the steering committee of the Italian Neurological Association (SIN), and Convenor for the Neuroepidemiology Section of the last meetings (Wien, Austria 2013) (Santiago, Chile 2015) of the World Federation of Neurology Congress. With more than 300 papers included in journals such as BMJ, JAMA, Lancet, Lancet Neurology, Annals of Neurology, Neurology and Brain, he is associate editor of the journal Neuroepidemiology, Karger, and Basel.